Company news
Organogenesis Holdings Inc. news in 2026
Organogenesis Holdings Inc.'s news releases, calls and decks from 2026, newest first.
Organogenesis Holdings Inc. Reports Third Quarter 2026 Financial Results
November 5, 2026
Organogenesis Announces Publication of Peer-Reviewed PREPARE Trial Results Demonstrating Clinical Benefit of PuraPly®AM for Hard-to-Heal Diabetic Foot Ulcers
October 12, 2026
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026
October 12, 2026
Organogenesis Holdings Inc. Reports Second Quarter 2026 Financial Results
August 6, 2026
Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers
July 27, 2026
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
July 9, 2026
Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis
July 6, 2026
Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results
May 7, 2026
Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®
April 27, 2026
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026
April 5, 2026
Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM
April 5, 2026
Organogenesis Holdings Inc. Reports Fourth Quarter 2025 Financial Results, Posts Record Revenue
February 26, 2026
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026
February 19, 2026
Calls in 2026
- Organogenesis Holdings (NASDAQ:ORGO) Q3 2026 Earnings Call
Nov 5, 2026
Transcript - Organogenesis Holdings (NASDAQ:ORGO) Q2 2026 Earnings Call
Aug 6, 2026
Transcript - Organogenesis Holdings (NASDAQ:ORGO) Q1 2026 Earnings Call
May 7, 2026
Transcript - Organogenesis Holdings (NASDAQ:ORGO) Q4 2025 Earnings Call
Feb 26, 2026
Transcript